BioCentury
ARTICLE | Financial News

Acumen announces first close of $20 million series A

April 26, 2013 1:04 AM UTC

Acumen Pharmaceuticals Inc. (Livermore, Calif.) raised an undisclosed amount in the first close of a $20 million series A financing led by existing investor BVF Partners. Existing investor NeuroVentures also participated, along with Praxis Technologies; Glynn Ventures; and private investors. ...